At Augusta Oncology, we pride ourselves on providing the latest technology and resources available to assist in all aspects of our patients’ fight against cancer. This is why we are excited to now offer the DigniCap® Scalp Cooling System at our Wheeler Road location to help prevent hair loss as a result of chemotherapy drugs. DigniCap is an option for patients receiving chemotherapy to treat solid tumors for breast cancer, as well as prostate, uterine, ovarian, lung, and others.

FDA-cleared for men & women with solid tumor cancers

What is it?

This new cooling system consists of a cooling cap for your head that is attached to a computerized cooling unit. The cap allows coolant to flow continuously through specifically designed channels to keep the temperature perfectly regulated. This continuous, cool temperature directly on your scalp is key for the effectiveness of the cap.

How it works

Chemotherapy drugs can damage hair cells, resulting in hair loss. By cooling the scalp with DigniCap, it has been proven to reduce chemotherapy-induced hair loss. This approach has been successfully used by thousands of patients worldwide. The cooling process kickstarts two reactions. The first is reduced blood flow to the scalp area, causing normal cellular activity in to slow dramatically. The second is reduced metabolism by lowering the scalp temperature, which also causes the normal cellular activity in the area to slow dramatically.


Chemotherapy may destroy your cancer, but it doesn’t have to destroy your hair.


Clinical Research

The DigniCap Scalp Cooling System has been studied at some of the most prestigious medical centers in the nation on patients with breast cancer. In its pivotal trial, the system was found to have prevented hair loss in 66.3% of patients receiving adjuvant chemotherapy compared to the control group who experienced significant hair loss.

If you would like to learn more about the DigniCap Scalp Cooling System, visit, or ask your oncologist if the DigniCap Scalp Cooling System is right for you.